Follicum

Activities: Research & Development

Trending Articles

  1. NHS, MHRA and Medicines UK launch Project Revive to tackle medicine shortages NHS England, the MHRA and Medicines UK have launched Project Revive, a collaborative pilot designed to address critical medicines shortages by fast-tracking dormant...
  2. Isopod Rapid Cleanrooms: the ideal elite controlled environment pod solution for Life Sciences and Engineering start-ups The Guardtech Group’s quick-assembly cleanroom pods combine superior performance, build quality and cost-effectiveness to give new applications the perfect platform to get...
  3. You need to be a subscriber to read this article.
    Click here to find out more.
    Delivering precision: why advanced therapies are redefining pharmaceutical logistics As advanced therapies narrow tolerances and personalise care, pharmaceutical logistics is being redefined as a precision-driven extension of treatment delivery, writes Michael...
  4. Nose-to-brain delivery outperforms systemic BBB technologies according to MetP Pharma The pioneering company has published preclinical data that strongly supports the advantages of its proprietary nose-to-brain drug delivery technology compared with systemic...
  5. AstraZeneca strengthens weight management pipeline with CSPC Pharmaceuticals collaboration The pair have signed a strategic collaboration covering eight obesity and type 2 diabetes programmes, including a clinical-ready GLP-1/GIP asset, AI-driven peptide discovery...

Upcoming event

High Shear = Mixing Success

19 February 2026 | Virtual See all

Related Content

Finance

Follicum appoints Jonas Edelswärd as CFO

During the period July 2018 to June 2019, he was a board member of Follicum
Finance

Follicum appoints CEO and establishes Chief Scientific Officer role

Current CEO Jan Alenfall will, for a period of at least six months continue to work in the company in the position of Chief Scientific Officer
Regulatory

Follicum obtains US patent for peptides

The patent will be formally approved on October 27, 2020
Pharmaceutical

Follicum selects new diabetes drug candidate

New peptide drug candidate that protect beta cells and address other diabetes complications to enter preclinical stages
Ingredients

Follicum teams up with University of Bradford on peptide research

Follicum signs agreement with Centre for Skin Sciences at University of Bradford for mode of action studies
Research & Development

Follicum expands patent portfolio

First diabetes patent published and promising experimental data supports new patent application
Research & Development

Follicum identifies receptors for potential new class of diabetes drug

This represents an important milestone in the continued development of Follicum's diabetes drug project, opening the possibility of the identified receptors becoming a potential drug target for stimulating insulin secretion and reducing diabetic complications
Subscribe now